Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia

Abroad (travel likely)RecruitingPHASE1

Conditions

Immune Thrombocytopenia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Contact: Principal Investigator (Heng Mei)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Antiphospholipid Syndrome (APS) · Bullous Pemphigoid (BP) · Behçet's Syndrome (BS)

Abroad (travel likely)RecruitingPHASE1

Orange, United States · Baltimore, United States

IASO-782 in Autoimmune Hematological Diseases

Autoimmune Thrombocytopenia · Warm Autoimmune Haemolytic Anaemia

Abroad (travel likely)RecruitingPHASE1

Wuhan, China · Tianjin, China

Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)

Primary Immune Thrombocytopenia (ITP)

Abroad (travel likely)RecruitingPHASE1

Guiyang, China · Nanchang, China

Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

Abroad (travel likely)RecruitingEARLY_PHASE1

Wuhan, China · Wuhan, China